Balloon Angioplasty with or without drug administration

DEVICE2 trials

Sponsors

University Hospital Tuebingen, Avtandil M. Babunashvili

Conditions

Arterial Occlusive DiseasesCoronary Artery Disease (CAD)Coronary Bifurcation LesionCoronary StentingDrug Eluting Balloon

Phase 2

Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries

University Hospital TuebingenArterial Occlusive Diseases

Start: 2004-07-31End: 2007-10-31Target: 135Updated: 2006-04-25

Unknown Phase

Stenting Versus Drug Eluting Balloons Only in Treatment of Coronary Bifurcation Lesion (ROBUST Study)

Not yet recruitingNCT07552194

Avtandil M. BabunashviliCoronary Artery Disease (CAD), Coronary Bifurcation Lesion, Coronary Stenting +1

Start: 2026-06-02End: 2028-02-20Target: 272Updated: 2026-04-27

Related Papers

Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial.

2015-01-01188 citations

High-grade, non-flow-limiting dissections do not negatively impact long-term outcome after paclitaxel-coated balloon angioplasty: an additional analysis from the THUNDER study.

2013-12-0148 citations

Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.

2008-02-01537 citations